Overall, our immunostaining data support the conclusion that matrix stiffness plays a dominant role in regulating GBM cell function, particularly AR and HSP27 expression, with softer environments promoting more biomimetic tumor phenotypes. This evidence concerns the gene AR and glioblastoma.